U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07493460) titled 'Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines' on Oct. 01, 2025.
Brief Summary: This study is being done to understand and measure how the immune system responds to and remembers different types of vaccines. To do this, four vaccines approved by the U.S. Food and Drug Administration (FDA) will be given simultaneously to participants. Participants will be volumteers who are healthy adults (18 years old or older) and willing to receive the yearly trivalent inactivated influenza vaccine (TIV), the tetanus, diphtheria, and acellular pertussis vaccine (Tdap), the nonvalent HPV (HPV) vaccine, hepat...